<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00318721</url>
  </required_header>
  <id_info>
    <org_study_id>CT-2005-015374</org_study_id>
    <nct_id>NCT00318721</nct_id>
  </id_info>
  <brief_title>Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar</brief_title>
  <acronym>KALANET</acronym>
  <official_title>Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>London School of Hygiene and Tropical Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute of Tropical Medicine, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rajendra Memorial Research Institute of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute of Medical Sciences of the Banaras Hindu University (BHU),India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>B.P. Koirala Institute of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>London School of Hygiene and Tropical Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cluster-randomized vector control trial in Bihar, India, and neighboring Nepal, will test
      the efficacy of long-lasting impregnated bednets (LLINs, Permanets) for reducing visceral
      leishmaniasis incidence. The intervention unit is the village (400-1000 people). The study is
      designed to detect a 50% reduction in Leishmania donovani incidence in intervention compared
      to control clusters over 2 years. 24 clusters (selected as high incidence during previous
      years) will be randomly allocated to intervention or control. Following health education, and
      with informed consent, all households in intervention villages will receive free Permanets
      (from September 2006). Net usage will be monitored and new nets provided if required. Control
      villages will not be given untreated nets, as - although commonly used in this region - their
      effectiveness against sandflies has not been proven. Pre-intervention infection status of
      villagers (&gt;2 yrs) will be evaluated serologically from finger-prick blood (and past/current
      disease status noted). Incident infections will be recorded by 3-monthly active search for
      clinical cases, and by annual serological diagnoses to detect subclinical infections. All
      villagers (&gt;2yrs) will be leishmanin skin tested at the end of the trial for further
      subclinical infection detection, and sera from a sub-sample will be tested for antibodies to
      sandfly saliva antigens (a measure of sandfly exposure). All clinical cases will be given
      free treatment. Free Permanets will be provided to control villages after the trial.
      Complementary studies involve entomological surveillance by light traps in a sample of houses
      and social/economic questionnaire surveys. The entomological surveys will test whether
      community-wide use of LLINs provides any mass effect, which could protect those in the
      community who fail to use LLIN for any reason.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>L. donovani infection</measure>
    <time_frame>yearly</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Kala Azar cases</measure>
    <time_frame>quarterly</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20000</enrollment>
  <condition>Visceral Leishmaniasis</condition>
  <condition>Kala Azar</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Long Lasting Impregnated Nets (LLIN)</intervention_name>
    <description>Distribution of LLIN in selected clusters</description>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria (Clusters):

          1. at least have seen 1 case per year in each of the last 3 years

          2. An average of at least 1% Incidence rate over the period of past 3 years.

        Exclusion criteria (Clusters):

          1. Minimum 500 people

          2. Maximum 2000 people

          3. Distance between clusters 2000 meters (distance between borders)

          4. Houses in tola/ward not sprayed (DDT, other) in 2006

          5. Accessibility
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marleen Boelaert, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prince Leopold Institute of Tropical Medicine in Antwerp (ITM), Belgium</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clive Davies, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>London School of Hygiene and Tropical Medicine, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Claude Dujardin, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prince Leopold Institute of Tropical Medicine in Antwerp (ITM), Belgium</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suman Rijal, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>B.P. Koirala Institute of Heath Sciences, Nepal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shyam Sundar, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Medical Sciences of the Banaras Hindu University (BHU),India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francois Chappuis, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Beena Varghese, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Health and Population Research (ICDDR,B), Dhaka, Bangladesh</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Coosemans, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prince Leopold Institute of Tropical Medicine in Antwerp (ITM), Belgium.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Veerle Vanlerberghe, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prince Leopold Institute of Tropical Medicine in Antwerp (ITM), Belgium.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Diwarkar Dinesh, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rajendra Memorial Research Institute of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kala Azar Medical Research Center</name>
      <address>
        <city>Muzaffarpur</city>
        <state>Bihar</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>B P Koirala Institute of Health Sciences</name>
      <address>
        <city>Dharan</city>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
    <country>Nepal</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2006</study_first_submitted>
  <study_first_submitted_qc>April 25, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2006</study_first_posted>
  <last_update_submitted>November 3, 2009</last_update_submitted>
  <last_update_submitted_qc>November 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof Marleen Boelaert</name_title>
    <organization>Institute of Tropical Medicine</organization>
  </responsible_party>
  <keyword>Leishmania donovani</keyword>
  <keyword>cluster-randomised control trial</keyword>
  <keyword>Long Lasting Impregnated Nets</keyword>
  <keyword>Bednets</keyword>
  <keyword>Sandflies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leishmaniasis</mesh_term>
    <mesh_term>Leishmaniasis, Visceral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

